Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Otaegui

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Plos One|July 21, 2009
Differential micro RNA expression in PBMC from multiple sclerosis patientsDavid Otaegui, Sergio E Baranzini, Ruben Armañanzas, et al.
International Journal of Molecular Sciences|August 22, 2018
The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis PatientsMatías Sáenz-Cuesta, Ainhoa Alberro, Maider Muñoz-Culla, et al.
Plos One|May 19, 2023
Early biochemical analysis of COVID-19 patients helps severity predictionAndrés Roncancio-Clavijo, Miriam Gorostidi-Aicua, Ainhoa Alberro, et al.
Aging Cell|May 21, 2024
Centenarian hippocampus displays high levels of astrocytic metallothioneinsAnder Saenz-Antoñanzas, Maider Muñoz-Culla, Piero Rigo, et al.
Aging|December 1, 2019
T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenariansAinhoa Alberro, Iñaki Osorio-Querejeta, Lucía Sepúlveda, et al.
Neurology|August 26, 2016
Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulationRoberto Fernández-Torrón, Mikel García-Puga, José-Ignacio Emparanza, et al.
Journal of Neuroimmunology|May 1, 2010
Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in SpainBhairavi Swaminathan, Fuencisla Matesanz, Mariá L Cavanillas, et al.
Biomarkers in Medicine|August 16, 2014
Circulating microparticles reflect treatment effects and clinical status in multiple sclerosisMatías Sáenz-Cuesta, Haritz Irizar, Tamara Castillo-Triviño, et al.
Annals of Neurology|September 3, 2002
Mitochondrial DNA depletion and dGK gene mutationsLeonardo Salviati, Sabrina Sacconi, Michelangelo Mancuso, et al.
Journal of Neuroinflammation|November 19, 2022
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosisCelia Camacho-Toledano, Isabel Machín-Díaz, Leticia Calahorra, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Plos One|July 21, 2009
Differential micro RNA expression in PBMC from multiple sclerosis patientsDavid Otaegui, Sergio E Baranzini, Ruben Armañanzas, et al.
International Journal of Molecular Sciences|August 22, 2018
The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis PatientsMatías Sáenz-Cuesta, Ainhoa Alberro, Maider Muñoz-Culla, et al.
Plos One|May 19, 2023
Early biochemical analysis of COVID-19 patients helps severity predictionAndrés Roncancio-Clavijo, Miriam Gorostidi-Aicua, Ainhoa Alberro, et al.
Aging Cell|May 21, 2024
Centenarian hippocampus displays high levels of astrocytic metallothioneinsAnder Saenz-Antoñanzas, Maider Muñoz-Culla, Piero Rigo, et al.
Aging|December 1, 2019
T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenariansAinhoa Alberro, Iñaki Osorio-Querejeta, Lucía Sepúlveda, et al.
Neurology|August 26, 2016
Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulationRoberto Fernández-Torrón, Mikel García-Puga, José-Ignacio Emparanza, et al.
Journal of Neuroimmunology|May 1, 2010
Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in SpainBhairavi Swaminathan, Fuencisla Matesanz, Mariá L Cavanillas, et al.
Biomarkers in Medicine|August 16, 2014
Circulating microparticles reflect treatment effects and clinical status in multiple sclerosisMatías Sáenz-Cuesta, Haritz Irizar, Tamara Castillo-Triviño, et al.
Annals of Neurology|September 3, 2002
Mitochondrial DNA depletion and dGK gene mutationsLeonardo Salviati, Sabrina Sacconi, Michelangelo Mancuso, et al.
Journal of Neuroinflammation|November 19, 2022
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosisCelia Camacho-Toledano, Isabel Machín-Díaz, Leticia Calahorra, et al.
Pageof 9